Serbian opposition lawmakers threw smoke grenades and tear gas inside parliament on Tuesday to protest against the government ...
21h
Hosted on MSNTenecteplase No Longer Off-Label as Stroke LyticNotably, off-label tenecteplase had already become the preferred thrombolytic for acute ischemic stroke before the expanded ...
Popovich has not coached since suffering what the Spurs described as a “mild stroke” on Nov. 2. His status for next season is ...
Discover how smoking and alcohol consumption dramatically increase stroke risk by raising blood pressure, damaging vessels, ...
Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...
3h
Woman&Home on MSNThis quick daily habit may reduce the risk of stroke and other heart conditions, a new study revealsWhen we think of ways to protect our hearts, diet and exercise often come to mind first. But while doing enough cardio and ...
The FDA has approved TNKase, a tissue plasminogen, clot-dissolving agent, to treat acute ischemic stroke in adults, according ...
A new Georgetown University Medical Center study exploring a new brain imaging technique is bringing stroke experts a step ...
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
Discover how hypertension, diabetes, atrial fibrillation, high cholesterol, and obesity increase stroke risk, and learn ...
The FDA has approved TNKase, a new, fast-acting stroke treatment that dissolves blood clots more efficiently, marking a significant advancement in stroke therapy and clot-busting technology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results